'96,000 die every year due to Hepatitis C in India'

Image
Press Trust of India New Delhi
Last Updated : Jul 25 2013 | 8:20 PM IST
Nearly 96,000 people die annually in India due to Hepatitis C, which has become a hidden epidemic and a silent killer, according to health activists.
Legal experts, doctors and activists brought together by NGO Indian drug users' forum (IDUF) today expressed concern over the growing rate of Hepatitis C in the country at a function held here to mark the World Hepatitis Day.
Citing a WHO report, the health activists said nearly four lakh Indians have been tested positive for Hepatitis C, leading to 96,000 annual deaths due to the viral infection.
The report said the prevalence of Hepatitis C is estimated to be within 1.8-2.5 per cent, while among drug users it is 50-90 per cent.
"Most Hepatitis C infections are among people who inject drugs. Thus, HCV infectiousness is ten times more contagious than HIV," said Leena Menghaney, a member of NGO 'Doctors without Border'.
The activists also accused the government of failing to formulate a policy to contain the disease.
"The failure of the Health Ministry to initiate steps to prevent the viral infection and proper treatment facilities is one of the reasons for spreading of the disease in India. It is time that we hold the government accountable for protecting public health," said Anand Grover, lawyer-activist and Special Rapporteur in UNHRC.
A WHO report titled 'Global policy report on prevention and control of viral Hepatitis' highlights non-collaboration of the government with civil society groups to develop and implement viral hepatitis prevention and control programme.
The activists said most often patients diagnosed with Hepatitis C lack access to affordable and appropriate treatment and medical care.
"One vial of interferon alfa by a private drug company costs Rs 23,100. Multiply the figure with 48 weeks and that's how much initial treatment would cost," said Loon Gangte of Delhi Network of Positive People, a group working for the welfare for people suffering from HIV+.
He is of the view that talking more about Hepatitis C and creating an awareness campaign like HIV-AIDS will get things moving.
"Training health care providers, establishing national treatment guidelines, introducing medication...Are some of the steps the Health Ministry must take, until a comprehensive national programme for prevention, control and treatment of viral hepatitis is launched," an activist said.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 25 2013 | 8:20 PM IST

Next Story